Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TELA Bio Inc TELA

Healthcare Medical Instruments & Supplies
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall... see more

Recent & Breaking News (NDAQ:TELA)

TELA Bio to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 27, 2020

GlobeNewswire March 11, 2020

TELA Bio Announces Publication of Results from In-Vivo Study Demonstrating Favorable Response to Reinforced Biologics in Hernia Repair

GlobeNewswire February 4, 2020

TELA Bio Announces Appointment of New Chief Commercial Officer

GlobeNewswire January 29, 2020

TELA Bio Announces Preliminary Revenue for Fourth Quarter and Full Year 2019

GlobeNewswire January 10, 2020

TELA Bio Announces Third Quarter 2019 Financial Results

GlobeNewswire December 18, 2019

TELA Bio Awarded Contract with HealthTrust Purchasing Group

GlobeNewswire December 6, 2019

TELA Bio Appoints Federica O'Brien to Board of Directors

GlobeNewswire November 13, 2019

TELA Bio Announces Closing of Initial Public Offering of Common Stock

GlobeNewswire November 13, 2019

TELA Bio Announces Pricing of Initial Public Offering of Common Stock

GlobeNewswire November 7, 2019